Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Ovarian Neoplasms

  Free Subscription


08.02.2010

1 Am J Obstet Gynecol
1 BMC Cancer
1 Cancer Chemother Pharmacol
1 Cancer Genet Cytogenet
2 Eur J Obstet Gynecol Reprod Biol
3 Int J Cancer
1 Int J Oncol
2 J Natl Cancer Inst
2 Oncogene
3 Oncol Rep
2 Oncology


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Obstet Gynecol

  1. CHEREAU E , Ballester M, Selle F, Cortez A, et al
    Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer.
    Am J Obstet Gynecol. 2010;202:178.
    PubMed     Text format     Related articles    Abstract available


    BMC Cancer

  2. MAW MK , Fujimoto J, Tamaya T
    Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers.
    BMC Cancer. 2009;9:430.
    PubMed     Text format     Related articles    Abstract available


    Cancer Chemother Pharmacol

  3. KUROKAWA T , He G, Siddik ZH
    Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner.
    Cancer Chemother Pharmacol. 2010;65:427-36.
    PubMed     Text format     Related articles    Abstract available


    Cancer Genet Cytogenet

  4. ZHANG X , Liu P, Zhang B, Wang A, et al
    Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells.
    Cancer Genet Cytogenet. 2010;197:46-53.
    PubMed     Text format     Related articles    Abstract available


    Eur J Obstet Gynecol Reprod Biol

  5. HEFLER-FRISCHMUTH K , Hefler LA, Heinze G, Paseka V, et al
    Serum C-reactive protein in the differential diagnosis of ovarian masses.
    Eur J Obstet Gynecol Reprod Biol. 2009.
    PubMed     Text format     Related articles    Abstract available

  6. MENCZER J
    Cox-2 expression in ovarian malignancies A review of the clinical aspects.
    Eur J Obstet Gynecol Reprod Biol. 2009.
    PubMed     Text format     Related articles    Abstract available


    Int J Cancer

  7. KARBACH J , Gnjatic S, Bender A, Neumann A, et al
    Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival.
    Int J Cancer. 2010;126:909-18.
    PubMed     Text format     Related articles    Abstract available

  8. ZUCO V , Benedetti V, De Cesare M, Zunino F, et al
    Sensitization of ovarian carcinoma cells to the atypical retinoid ST1926 by the histone deacetylase inhibitor, RC307: Enhanced DNA damage response.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available

  9. BROTIN E , Meryet-Figuiere M, Simonin K, Duval RE, et al
    Bcl-x(L) and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available


    Int J Oncol

  10. PASQUINI L , Petronelli A, Petrucci E, Saulle E, et al
    Primary ovarian cancer cells are sensitive to the proaptotic effects of proteasome inhibitors.
    Int J Oncol. 2010;36:707-13.
    PubMed     Text format     Related articles    Abstract available


    J Natl Cancer Inst

  11. ROSSING MA , Wicklund KG, Cushing-Haugen KL, Weiss NS, et al
    Predictive Value of Symptoms for Early Detection of Ovarian Cancer.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles    Abstract available

  12. CASS I , Karlan BY
    Ovarian Cancer Symptoms Speak Out--But What Are They Really Saying?
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles   


    Oncogene

  13. CHEUNG LW , Leung PC, Wong AS
    Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available

  14. WOLF I , Laitman Y, Rubinek T, Abramovitz L, et al
    Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available


    Oncol Rep

  15. LIU JJ , Lin B, Hao YY, Li FF, et al
    Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway.
    Oncol Rep. 2010;23:833-41.
    PubMed     Text format     Related articles    Abstract available

  16. YOSHIHARA C , Hamada K, Koyama Y
    Preparation of a novel adenovirus formulation with artificial envelope of multilayer polymer-coatings: Therapeutic effect on metastatic ovarian cancer.
    Oncol Rep. 2010;23:733-8.
    PubMed     Text format     Related articles    Abstract available

  17. ROOMI MW , Monterrey JC, Kalinovsky T, Rath M, et al
    In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors.
    Oncol Rep. 2010;23:605-14.
    PubMed     Text format     Related articles    Abstract available


    Oncology

  18. TIERSTEN AD , Moon J, Smith HO, Wilczynski SP, et al
    Chemotherapy Resistance as a Predictor of Progression-Free Survival in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy and Surgical Cytoreduction Followed by Intraperitoneal Chemotherapy: A Southwest Oncology Group Study.
    Oncology. 2010;77:395-399.
    PubMed     Text format     Related articles    Abstract available

  19. BAI Y , Deng H, Yang Y, Zhao X, et al
    VEGF-Targeted Short Hairpin RNA Inhibits Intraperitoneal Ovarian Cancer Growth in Nude Mice.
    Oncology. 2010;77:385-394.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: